• FirefoxInstall the new Firefox »
  •  Dow Down0.47% Nasdaq Down0.56%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    13.87 Down 0.11(0.79%) Mar 3, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 9,336   10,950   10,785   12,749  
    Cost of Revenue -   -   -   -  
    Gross Profit 9,336   10,950   10,785   12,749  
    Operating Expenses
    Research Development27,508  26,089  26,692  32,228  
    Selling General and Administrative11,103  11,219  11,717  10,855  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (29,275) (26,358) (27,624) (30,334)
    Income from Continuing Operations
    Total Other Income/Expenses Net174  202  262  273  
    Earnings Before Interest And Taxes(29,101)(26,156)(27,362)(30,061)
    Interest Expense -   -   -   -  
    Income Before Tax(29,101)(26,156)(27,362)(30,061)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(29,101)(26,156)(27,362)(30,061)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (29,101) (26,156) (27,362) (30,061)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (29,101) (26,156) (27,362) (30,061)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.